Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells

Journal of Immunology

Volumn 186, Issue 2, 2011, Pages 791-798

  Griffith, Thomas S ^a,b   Brincks, Erik L ^a,b   Gurung, Prajwal ^a,b   Kucaba, Tamara A ^a   Ferguson, Thomas A ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; EYE INFLAMMATION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; WILD TYPE;

ANIMALS; ANTERIOR CHAMBER; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; EYE; HERPESVIRUS 1, HUMAN; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; INJECTIONS, INTRAOCULAR; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SPLEEN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; VERO CELLS;

EID: 79251561556     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002678     Document Type: Article

References (54)

1. Van Dooremaal, J. C. 1873. Die entwickelung der in fremden grund versetzten ledenden gewebe. Albrect von Graefe's Acrh. Ophthalmol. 19: 359-373.
2. Medawar, P. B. 1948. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29: 58-69.
3. Cousins, S. W., M. M. McCabe, D. Danielpour, and J. W. Streilein. 1991. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 32: 2201-2211.
4. Grabbe, S., S. Bruvers, R. L. Gallo, T. L. Knisely, R. Nazareno and R. D. Granstein. 1991. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146: 3656-3661.
5. Hooper, P., N. S. Bora, H. J. Kaplan, and T. A. Ferguson. 1991. Inhibition of lymphocyte proliferation by resident ocular cells. Curr. Eye Res. 10: 363-372.
6. Wilbanks, G. A., and J. W. Streilein. 1990. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 71: 383-389.
7. Ferguson, T. A., S. Fletcher, J. Herndon, and T. S. Griffith. 1995. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J. Immunol. 155: 1746-1756.
8. Akdis, M., J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, et al. 2004. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199: 1567-1575.
9. Apte, R. S., and J. Y. Niederkorn. 1996. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J. Immunol. 156: 2667-2673.
10. Kaplan, H. J., and J. W. Streilein. 1977. Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J. Immunol. 118: 809-814.
11. Wetzig, R. P., C. S. Foster, and M. I. Greene. 1982. Ocular immune responses. I. Priming of A/J mice in the anterior chamber with azobenzenearsonate-derivatized cells induces second-order-like suppressor T cells. J. Immunol. 128: 1753-1757.
12. Ferguson, T. A., and G. M. Iverson. 1986. Isolation and characterization of an antigen-specific suppressor inducer molecule from serum of hyperimmune mice by using a monoclonal antibody. J. Immunol. 136: 2896-2903.
13. Ferguson, T. A., J. C. Waldrep, and H. J. Kaplan. 1987. The immune response and the eye. II. The nature of T suppressor cell induction in anterior chamber-associated immune deviation (ACAID). J. Immunol. 139: 352-357.
14. Ferguson, T. A., J. D. Hayashi, and H. J. Kaplan. 1989. The immune response and the eye. III. Anterior chamber-associated immune deviation can be adoptively transferred by serum. J. Immunol. 143: 821-826.
15. Sonoda, Y., and J. W. Streilein. 1993. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J. Immunol. 150: 1727-1734.
16. Ferguson, T. A., and J. M. Herndon. 1994. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen. Invest. Ophthalmol. Vis. Sci. 35: 3085-3093.
17. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192.
18. Griffith, T. S., X. Yu, J. M. Herndon, D. R. Green, and T. A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5: 7-16.
19. Stuart, P. M., T. S. Griffith, N. Usui, J. Pepose, X. Yu, and T. A. Ferguson. 1997. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest. 99: 396-402.
20. Abbas, A. K. 1996. Die and let live: eliminating dangerous lymphocytes. Cell 84: 655-657.
21. Ferguson, T. A., J. D. Hayashi, and H. J. Kaplan. 1988. Regulation of the systemic immune response by visible light and the eye. FASEB J. 2: 3017-3021.
22. Whittum-Hudson, J., M. Farazdaghi, and R. A. Prendergast. 1985. A role for T lymphocytes in preventing experimental herpes simplex virus type 1-induced retinitis. Invest. Ophthalmol. Vis. Sci. 26: 1524-1532.
23. Streilein, J. W., and J. Y. Niederkorn. 1981. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J. Exp. Med. 153: 1058-1067.
24. Sedger, L. M., M. B. Glaccum, J. C. Schuh, S. T. Kanaly, E. Williamson, N. Kayagaki, T. Yun, P. Smolak, T. Le, R. Goodwin, and B. Gliniak. 2002. Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. Eur. J. Immunol. 32: 2246-2254.
25. Finnberg, N., J. J. Gruber, P. Fei, D. Rudolph, A. Bric, S. H. Kim, T. F. Burns, H. Ajuha, R. Page, G. S. Wu, et al. 2005. DR5 knockout mice are compromised in radiation-induced apoptosis. Mol. Cell. Biol. 25: 2000-2013.
26. Ehst, B. D., E. Ingulli, and M. K. Jenkins. 2003. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am. J. Transplant. 3: 1355-1362.
27. Ferguson, T. A., J. Herndon, B. Elzey, T. S. Griffith, S. Schoenberger, and D. R. Green. 2002. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. J. Immunol. 168: 5589-5595.
28. Griffith, T. S., H. Kazama, R. L. VanOosten, J. K. Earle, Jr., J. M. Herndon, D. R. Green, and T. A. Ferguson. 2007. Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J. Immunol. 178: 2679-2687.
29. Ferguson, T. A., D. R. Green, and T. S. Griffith. 2002. Cell death and immune privilege. Int. Rev. Immunol. 21: 153-172.
30. Ferguson, T. A., P. M. Stuart, J. M. Herndon, and T. S. Griffith. 2003. Apoptosis, tolerance, and regulatory T cells - old wine, new wineskins. Immunol. Rev. 193: 111-123.
31. Bennett, S. R., F. R. Carbone, F. Karamalis, J. F. Miller, and W. R. Heath. 1997. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J. Exp. Med. 186: 65-70.
32. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
33. Albert, M. L., M. Jegathesan, and R. B. Darnell. 2001. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2: 1010-1017.
34. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93.
35. Wilbanks, G. A., and J. W. Streilein. 1989. The differing patterns of antigen release and local retention following anterior chamber and intravenous inoculation of soluble antigen. Evidence that the eye acts as an antigen depot. Reg. Immunol. 2: 390-398.
36. Griffith, T. S., J. M. Herndon, J. Lima, M. Kahn, and T. A. Ferguson. 1995. The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eye. Int. Immunol. 7: 1617-1625.
37. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
38. Griffith, T. S., and D. H. Lynch. 1998. TRAIL: a molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 10: 559-563.
39. Lee, H. O., J. M. Herndon, R. Barreiro, T. S. Griffith, and T. A. Ferguson. 2002. TRAIL: a mechanism of tumor surveillance in an immune privileged site. J. Immunol. 169: 4739-4744.
40. Ma, H., Y. Liu, S. Liu, H. F. Kung, X. Sun, D. Zheng, and R. Xu. 2005. Recombinant adeno-associated virus-mediated TRAIL gene therapy suppresses liver metastatic tumors. Int. J. Cancer 116: 314-321. (Pubitemid 40967271)
41. Song, K., Y. Chen, R. Göke, A. Wilmen, C. Seidel, A. Göke, B. Hilliard, and Y. Chen. 2000. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J. Exp. Med. 191: 1095-1104.
42. Mi, Q. S., D. Ly, S. E. Lamhamedi-Cherradi, K. V. Salojin, L. Zhou, M. Grattan, C. Meagher, P. Zucker, Y. H. Chen, J. Nagle, et al. 2003. Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice. Diabetes 52: 1967-1975.
43. Brincks, E. L., A. Katewa, T. A. Kucaba, T. S. Griffith, and K. L. Legge. 2008. CD8 T cells utilize TRAIL to control influenza virus infection. J. Immunol. 181: 4918-4925.
44. Ishikawa, E., M. Nakazawa, M. Yoshinari, and M. Minami. 2005. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice. J. Virol. 79: 7658-7663.
45. Sato, K., S. Hida, H. Takayanagi, T. Yokochi, N. Kayagaki, K. Takeda, H. Yagita, K. Okumura, N. Tanaka, T. Taniguchi, and K. Ogasawara. 2001. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur. J. Immunol. 31: 3138-3146.
46. Raftery, M. J., C. K. Behrens, A. Müller, P. H. Krammer, H. Walczak, and G. Schönrich. 1999. Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med. 190: 1103-1114.
47. Ferguson, T. A., S. L. Mahendra, P. Hooper, and H. J. Kaplan. 1992. The wavelength of light governing intraocular immune reactions. Invest. Ophthalmol. Vis. Sci. 33: 1788-1795.
48. Ferguson, T. A., J. M. Herndon, and P. Dube. 1994. The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation. Invest. Ophthalmol. Vis. Sci. 35: 2643-2651.
49. Gurung, P., T. A. Kucaba, S. P. Schoenberger, T. A. Ferguson, and T. S. Griffith. 2010. TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion. J. Leukoc. Biol. 88: 1217-1225.
50. Tripathi, R. C. 1977. Uveoscleral drainage of aqueous humour. Exp. Eye Res. 25 (Suppl): 305-308.
51. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101: 890-898.
52. Gao, Y., J. M. Herndon, H. Zhang, T. S. Griffith, and T. A. Ferguson. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188: 887-896.
53. Chen, W., M. E. Frank, W. Jin, and S. M. Wahl. 2001. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14: 715-725.
54. Steinman, R. M., S. Turley, I. Mellman, and K. Inaba. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191: 411-416.